DeveloGen AG, Germany Report issue

For profit Phase 1 Phase 2
Founded: Gottingen Germany (1997)
Status: Acquired by Evotec (2010)

Organization Overview

First Clinical Trial
2002
NCT00058981
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DeveloGen Israel, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

diapep277 (1 trial)

Drugs in Phase 1 Trials (1)

somatoprim (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Latent Autoimmune Diabetes in Adults (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2